Literature DB >> 26765764

Non-Wilsonian hepatolenticular degeneration: Clinical and MRI observations in four families from south India.

Madhu Nagappa1, Sanjib Sinha2, Jitender S Saini3, Pradeep Kallolimath1, Nivedita Singh4, Arun Kumar4, Parayil S Bindu1, Arun B Taly1.   

Abstract

Non-Wilsonian hepatolenticular degeneration (NWHD) is a heterogeneous neurological disorder occurring secondary to chronic acquired liver disease. Genetically determined familial NWHD is rare, poorly understood, and often mistaken for Wilson's disease (WD). We analysed clinical and MRI profiles of NWHD patients who did not have obvious cause for acquired liver disease, such as alcohol intake or hepatitis. Six patients from four families (four males, two females, mean age: 17.0±standard deviation 7.9years), presenting with chronic extrapyramidal disorder resembling WD and imaging (abdominal ultrasound/MRI) evidence of cirrhosis were studied. They lacked Kayser-Fleischer rings or biochemical and/or genetic evidence of WD. Clinical features included dystonia (n=6), parkinsonism (n=3), tremor (n=1), cerebellar ataxia (n=3), orofacial dyskinesia (n=1), behavioural abnormalities (n=3), and cognitive decline (n=1). Brain MRI revealed T1-weighted hyperintensity in the pallidum (n=6), crus cerebri (n=4), putamen (n=1), caudate (n=1), thalamus (n=1), and red nucleus (n=1) with T2-weighted shortening in some of these regions. Additional findings included giant cisterna magna (n=1), face of giant panda sign (n=1) and thin corpus callosum (n=1). Areas of "blooming" on susceptibility weighted images were noted in two patients in the caudate (n=2) and putamen (n=1). The finding of T1 shortening is distinct from that of WD where the majority of lesions are T1-hypointense and T2-hyperintense. Extrapallidal T1-hyperintensity is also an exceptional observation in NWHD. The MRI appearance of intense T1 shortening coupled with the lack of increased susceptibility changes suggests that the most likely mineral deposited is manganese. The association of this neurological disorder and cirrhosis of the liver in the absence of an acquired liver disease is a distinct disease entity. This syndrome may represent a disorder of manganese metabolism resulting in its toxic deposition.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Liver dysfunction; MRI; Manganese; Non-Wilsonian hepatolenticular degeneration; Pallidal hyperintensity; Wilson’s disease

Mesh:

Substances:

Year:  2016        PMID: 26765764     DOI: 10.1016/j.jocn.2015.06.035

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

Review 1.  Neuroimaging Pearls from the MDS Congress Video Challenge. Part 1: Genetic Disorders.

Authors:  Diana A Olszewska; Sapna Rawal; Conor Fearon; Paula Alcaide-Leon; Rick Stell; Vijayashankar Paramanandan; Tim Lynch; Tania Jawad; Padmaja Vittal; Brandon Barton; Hiroaki Miyajima; Satoshi Kono; Rukmini Mridula Kandadai; Rupam Borgohain; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2022-02-03

2.  Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

3.  A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis.

Authors:  Diana Apetauerova; Peter Hildebrand; Stephanie Scala; Janet W Zani; LeeAnne Lipert; Erin Clark; Tanya Fennell; Fredric D Gordon
Journal:  Hepatol Commun       Date:  2020-11-26

Review 4.  Recent Updates on Acquired Hepatocerebral Degeneration.

Authors:  Hae-Won Shin; Hee Kyung Park
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.